News - Polygon Health Analytics (Page 2)

To My Fellow Data Scientists: Transform a Useful Idea into a Real Business

Jun 23, 2024

I have been building my own startup company for the past 1.5 years. Throughout this journey, I’ve been fortunate to connect with many brilliant...

Polygon Health Analytics to Present AI-driven chart review capabilities at ISPOR 2024

Apr 25, 2024

Polygon Health Analytics is proud to announce the development of a groundbreaking capability – a Large Language Model (LLM)-facilitated chart review solution. This application of advanced...

Navigating the Future: Your Launchpad to Success in Data Analytics

Mar 12, 2024

In today’s ever-evolving job market, the challenge of securing employment is a topic that resonates widely. Through news media and personal stories from friends and...

Bridging the Gap: Real-World Data Enhancing Clinical Trials

Mar 12, 2024

Randomized clinical trials (RCTs) have long been recognized as the gold standard for testing the safety and efficacy of pharmaceutical interventions. Despite their rigorous methodology, RCTs...

A Symphony of Innovation in 2023: Navigating the AI Revolution

Jan 26, 2024

Prelude to Power: OpenAI’s ChatGPT takes the lead In the waning months of 2022, OpenAI unveiled ChatGPT, marking a pivotal moment in the AI landscape....

Polygon Health Analytics to Showcase Lupus Research at ACR 2023 Conference

Oct 02, 2023

Polygon Health Analytics will present two research projects on Systemic Lupus Erythematosus (SLE), through collaboration with Temple University and the University of Florida at ACR 2023...

FAQs about the FDA Guidance on the Use of Real-World Data and Real-World Evidence to Support Regulatory Decision-Making for Drug and Biological Products

Sep 18, 2023

Analyzing real-world data (RWD)1 to generate real-world evidence (RWE)2 is an emerging trend in the healthcare community. RWE is routinely used to evaluate a...

Leveraging Large Language Models like ChatGPT for Real-World Evidence Generation

Sep 12, 2023

Large Language Models (LLMs), including ChatGPT, have gained significant traction since late 2022, sparking debates about whether they’re mere hype or a genuine revolution. However,...

Health Economics and Outcomes Research (HEOR): A Tool to Navigate the Biopharmaceutical Marathon

Jun 12, 2023

Congratulations! The decision to embark on the journey of founding a biopharmaceutical company is a courageous step indeed. Remember, as Tony Wheeler put it, “All you’...

The Invisible Disease

May 06, 2023

“I got diagnosed in my early 20s” “I wanted to so badly say, ‘You guys have no idea. I’m in chemotherapy. You’re a–holes....

We Now Accepting Online Credit Card Payments for Client Convenience

Apr 11, 2023

We are thrilled to announce that we now accept online credit card payments for our clients through Stripe, a safe and convenient online payment company. This...

One drug, two Prices: Understanding the Role of Pharmacy Benefit Managers in US Drug Pricing

Mar 07, 2023

Humira, a top-selling drug with $200 billion in revenue over two decades, recently lost its patent monopoly. This paved the way for biosimilars like Amjevita to...